Access the full text.
Sign up today, get DeepDyve free for 14 days.
V. Pengo, A. Ruffatti, C. Legnani, P. Gresele, D. Barcellona, N. Erba, S. Testa, F. Marongiu, E. Bison, G. Denas, A. Banzato, S. Jose, S. Iliceto (2010)
Clinical course of high‐risk patients diagnosed with antiphospholipid syndromeJournal of Thrombosis and Haemostasis, 8
S. Pierangeli, G. Girardi, M. Vega-Ostertag, Xiaowei Liu, R. Espinola, J. Salmon (2005)
Requirement of activation of complement C3 and C5 for antiphospholipid antibody-mediated thrombophilia.Arthritis and rheumatism, 52 7
G. Bertsias, M. Tektonidou, Z. Amoura, M. Aringer, I. Bajema, J. Berden, J. Boletis, R. Cervera, T. Dörner, A. Doria, F. Ferrario, J. Floege, F. Houssiau, J. Ioannidis, D. Isenberg, C. Kallenberg, L. Lightstone, S. Marks, A. Martini, G. Moroni, I. Neumann, M. Praga, Matthias Schneider, Argyre Starra, V. Tesar, C. Vasconcelos, R. Vollenhoven, H. Zakharova, M. Haubitz, C. Gordon, D. Jayne, D. Boumpas (2012)
Joint European League Against Rheumatism and European Renal Association–European Dialysis and Transplant Association (EULAR/ERA-EDTA) recommendations for the management of adult and paediatric lupus nephritisAnnals of the Rheumatic Diseases, 71
Da Thompson, A. Juby, P. Davis (1993)
The Clinical Significance of Autoantibody Profiles in Patients with Systemic Lupus ErythematosusLupus, 2
C. Trenor, Richard Chung, A. Michelson, E. Neufeld, C. Gordon, M. Laufer, S. Emans (2011)
Hormonal Contraception and Thrombotic Risk: A Multidisciplinary ApproachPediatrics, 127
G. Ruiz-Irastorza, M. Khamashta (2008)
Lupus and pregnancy: ten questions and some answersLupus, 17
Gabriela Cesarman-Maus, N. Ríos-Luna, A. Deora, Bihui Huang, R. Villa, M. Cravioto, D. Alarcon-segovia, J. Sánchez-Guerrero, K. Hajjar (2005)
Autoantibodies against the fibrinolytic receptor, annexin 2, in antiphospholipid syndrome.Blood, 107 11
G. Hughes (2003)
Migraine, memory loss, and “multiple sclerosis ”. Neurological features of the antiphospholipid (Hughes’) syndromePostgraduate Medical Journal, 79
C. Pericleous, Lindsey Clarke, P. Brogan, D. Latchman, D. Isenberg, Y. Ioannou, I. Giles, Anisur Rahman (2012)
Endothelial microparticle release is stimulated in vitro by purified IgG from patients with the antiphospholipid syndromeThrombosis and Haemostasis, 109
J. Rand, Xiao-Xuan Wu, Anthony Quinn, A. Ashton, Pojen Chen, J. Hathcock, H. Andree, D. Taatjes (2010)
Hydroxychloroquine protects the annexin A5 anticoagulant shield from disruption by antiphospholipid antibodies: evidence for a novel effect for an old antimalarial drug.Blood, 115 11
F. Dignat-George, L. Camoin-Jau, F. Sabatier, D. Arnoux, F. Anfosso, N. Bardin, V. Veit, V. Combes, S. Gentile, Valérie Moal, M. Sanmarco, J. Sampol (2004)
Endothelial microparticles: a potential contribution to the thrombotic complications of the antiphospholipid syndromeThrombosis and Haemostasis, 91
P. Groot, R. Derksen (2005)
Pathophysiology of the antiphospholipid syndromeJournal of Thrombosis and Haemostasis, 3
J. Arvieux, L. Darnige, C. Caron, G. Reber, J. Bensa, M. Colomb (1995)
Development of an ELISA for Autoantibodies to Prothrombin Showing their Prevalence in Patients with Lupus AnticoagulantsThrombosis and Haemostasis, 74
G. Emmi, E. Silvestri, D. Squatrito, L. Ciucciarelli, A. Cameli, G. Denas, M. D’Elios, V. Pengo, L. Emmi, D. Prisco (2014)
An Approach to Differential Diagnosis of Antiphospholipid Antibody Syndrome and Related ConditionsThe Scientific World Journal, 2014
F. Cowchock, E. Reece, D. Balaban, D. Branch, L. Plouffe (1992)
Repeated fetal losses associated with antiphospholipid antibodies: a collaborative randomized trial comparing prednisone with low-dose heparin treatment.American journal of obstetrics and gynecology, 166 5
I. Uthman, B. Godeau, A. Taher, M. Khamashta (2008)
The hematologic manifestations of the antiphospholipid syndrome.Blood reviews, 22 4
M. Nagahama, S. Nomura, S. Kanazawa, Y. Ozaki, H. Kagawa, S. Fukuhara (2003)
Significance of Anti-oxidized LDL Antibody and Monocyte-derived Microparticles in Anti-phospholipid Antibody SyndromeAutoimmunity, 36
M. Sikara, J. Routsias, M. Samiotaki, G. Panayotou, H. Moutsopoulos, P. Vlachoyiannopoulos (2010)
{beta}2 Glycoprotein I ({beta}2GPI) binds platelet factor 4 (PF4): implications for the pathogenesis of antiphospholipid syndrome.Blood, 115 3
D. Yetman, W. Kutteh (1996)
Antiphospholipid antibody panels and recurrent pregnancy loss: prevalence of anticardiolipin antibodies compared with other antiphospholipid antibodies.Fertility and sterility, 66 4
M. Zucker, I. Katz (1991)
Platelet Factor 4: Production, Structure, and Physiologic and Immunologic ActionProceedings of the Society for Experimental Biology and Medicine, 198
M. Tektonidou (2014)
Identification and treatment of APS renal involvementLupus, 23
K. Bramham, B. Hunt, S. Germain, I. Calatayud, M. Khamashta, S. Bewley, C. Nelson-Piercy (2010)
Pregnancy outcome in different clinical phenotypes of antiphospholipid syndromeLupus, 19
J Pereira, G Alfaro, M Goycoolea (2006)
Circulating platelet-derived microparticles in systemic lupus erythematosus. Association with increased thrombin generation and procoagulant stateThromb Haemost, 95
E. Bevers, M. Galli, T. Barbui, P. Comfurius, R. Zwaal (1991)
Lupus Anticoagulant IgG's (LA) Are Not Directed to Phospholipids only, but to a Complex of Lipid-Bound Human ProthrombinThrombosis and Haemostasis, 66
I. Uthman, A. Gharavi (2002)
Viral infections and antiphospholipid antibodies.Seminars in arthritis and rheumatism, 31 4
J. Gómez-Puerta, R. Cervera (2014)
Diagnosis and classification of the antiphospholipid syndrome.Journal of autoimmunity, 48-49
V Pengo, A Tripodi, G Reber (2009)
Update of the guidelines for lupus anticoagulant detection. Subcommittee on Lupus Anticoagulant/Antiphospholipid Antibody of the Scientific and Standardisation Committee of the International Society on Thrombosis and HaemostasisJ Thromb Haemost, 7
D. Robbins, S. Leung, D. Miller-Blair, V. Ziboh (1998)
Effect of anticardiolipin/beta2-glycoprotein I complexes on production of thromboxane A2 by platelets from patients with the antiphospholipid syndrome.The Journal of rheumatology, 25 1
G. Espinosa, R. Cervera, R. Asherson (2007)
Catastrophic antiphospholipid syndrome and sepsis. A common link?The Journal of rheumatology, 34 5
A. Ruffatti, M. Tonello, T. Ross, A. Cavazzana, C. Grava, F. Noventa, F. Tona, S. Iliceto, V. Pengo (2006)
Antibody profile and clinical course in primary antiphospholipid syndrome with pregnancy morbidityThrombosis and Haemostasis, 96
R. Asherson, R. Cervera, P. Groot, D. Erkan, M. Boffa, J. Piette, M. Khamashta, Y. Shoenfeld (2003)
Catastrophic antiphospholipid syndrome: international consensus statement on classification criteria and treatment guidelinesLupus, 12
M. Rottem, I. Krause, A. Fraser, L. Stojanovich, J. Rovensky, Yehuda Shoenfeld (2006)
Autoimmune Hemolytic Anaemia in the Antiphospholipid SyndromeLupus, 15
V. Pengo, E. Bison, G. Denas, S. Jose, A. Bracco, A. Banzato (2014)
The Paradox of the Lupus Anticoagulant: History and PerspectivesSeminars in Thrombosis & Hemostasis, 40
G. Pons-Estel, R. Cervera (2014)
Renal Involvement in Antiphospholipid SyndromeCurrent Rheumatology Reports, 16
J. Gómez-Puerta, R. Cervera, G. Espinosa, S. Aguiló, S. Bucciarelli, M. Ramos-Casals, M. Ingelmo, R. Asherson, J. Font (2006)
Antiphospholipid antibodies associated with malignancies: clinical and pathological characteristics of 120 patients.Seminars in arthritis and rheumatism, 35 5
R. Diz‐Kucukkaya, A. Hacıhanefioğlu, M. Yenerel, M. Turgut, H. Keskin, M. Nalçacı, M. Inanç (2001)
Antiphospholipid antibodies and antiphospholipid syndrome in patients presenting with immune thrombocytopenic purpura: a prospective cohort study.Blood, 98 6
B. Giannakopoulos, S. Krilis (2009)
How I treat the antiphospholipid syndrome.Blood, 114 10
R. Cervera, J. Piette, J. Font, M. Khamashta, Y. Shoenfeld, M. Camps, S. Jacobsen, G. Lakos, A. Tincani, I. Kontopoulou-Griva, M. Galeazzi, P. Meroni, R. Derksen, P. Groot, E. Gromnica-ihle, M. Baleva, M. Mosca, S. Bombardieri, F. Houssiau, J. Gris, I. Quéré, E. Hachulla, C. Vasconcelos, B. Roch, A. Fernández-Nebro, M. Boffa, G. Hughes, M. Ingelmo (2002)
Antiphospholipid syndrome: clinical and immunologic manifestations and patterns of disease expression in a cohort of 1,000 patients.Arthritis and rheumatism, 46 4
D. Branch, A. Peaceman, M. Druzin, R. Silver, Y. El‐Sayed, R. Silver, M. Esplin, J. Spinnato, J. Harger (2000)
A multicenter, placebo-controlled pilot study of intravenous immune globulin treatment of antiphospholipid syndrome during pregnancy. The Pregnancy Loss Study Group.American journal of obstetrics and gynecology, 182 1 Pt 1
C. Nalli, L. Andreoli, C. Casu, A. Tincani (2014)
Management of Recurrent Thrombosis in Antiphospholipid SyndromeCurrent Rheumatology Reports, 16
V. Salle, J. Mazière, A. Smail, R. Cevallos, C. Maziére, V. Fuentes, B. Tramier, R. Makdassi, G. Choukroun, O. Vittecoq, V. Goeb, J. Ducroix (2008)
Anti-annexin II Antibodies in Systemic Autoimmune Diseases and Antiphospholipid SyndromeJournal of Clinical Immunology, 28
N. Simone, P. Meroni, N. Papa, E. Raschi, D. Caliandro, S. Carolis, M. Khamashta, T. Atsumi, G. Hughes, G. Balestrieri, A. Tincani, Paolo Casali, A. Caruso (2000)
Antiphospholipid antibodies affect trophoblast gonadotropin secretion and invasiveness by binding directly and through adhered beta2-glycoprotein I.Arthritis and rheumatism, 43 1
R. Silver, S. MacGregor, J. Sholl, J. Hobart, M. Neerhof, A. Ragin (1993)
Comparative trial of prednisone plus aspirin versus aspirin alone in the treatment of anticardiolipin antibody-positive obstetric patients.American journal of obstetrics and gynecology, 169 6
J. Rand, Xiao-Xuan Wu, Anthony Quinn, Pojen Chen, J. Hathcock, D. Taatjes (2008)
Hydroxychloroquine directly reduces the binding of antiphospholipid antibody-beta2-glycoprotein I complexes to phospholipid bilayers.Blood, 112 5
J. Piette, Z. Amoura, B. Wechsler, C. Francès (1998)
[Neurological manifestations of antiphospholipid syndrome].La Revue de medecine interne, 19 Suppl 1
B. Laat, V. Pengo, I. Pabinger, J. Musial, A. Voskuyl, I. Bultink, A. Ruffatti, B. Rozman, T. Kveder, P. Moerloose, F. Boehlen, J. Rand, Z. Ulčová-Gallová, K. Mertens, P. Groot (2009)
The association between circulating antibodies against domain I of beta2‐glycoprotein I and thrombosis: an international multicenter studyJournal of Thrombosis and Haemostasis, 7
Rabih Nayfe, I. Uthman, J. Aoun, Ehab Aldin, M. Merashli, M. Khamashta (2013)
Seronegative antiphospholipid syndrome.Rheumatology, 52 8
S. Miyakis, M. Lockshin, T. Atsumi, D. Branch, R. Brey, R. Cervera, R. Derksen, P. Groot, T. Koike, P. Meroni, G. Reber, Y. Shoenfeld, A. Tincani, P. Vlachoyiannopoulos, S. Krilis (2006)
International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS)Journal of Thrombosis and Haemostasis, 4
N. Barteneva, E. Fasler‐Kan, M. Bernimoulin, Joel Stern, E. Ponomarev, L. Duckett, I. Vorobjev (2013)
Circulating microparticles: square the circleBMC Cell Biology, 14
G. Hughes (1983)
Thrombosis, abortion, cerebral disease, and the lupus anticoagulant.British Medical Journal (Clinical research ed.), 287
A. Mirrakhimov, N. Hill (2014)
Primary antiphospholipid syndrome and pulmonary hypertension.Current pharmaceutical design, 20 4
M. Petri (2000)
Epidemiology of the antiphospholipid antibody syndrome.Journal of autoimmunity, 15 2
F. Carmona, M. Azulay, M. Creus, F. Fábregues, B. Puerto, J. Balasch, J. Font, R. Cervera (2001)
Risk Factors Associated with Fetal Losses in Treated Antiphospholipid Syndrome Pregnancies: A Multivariate AnalysisAmerican Journal of Reproductive Immunology, 46
E. Vaquero, H. Valensise, S. Menghini, G. Pierro, C. Romanini, N. Lazzarin, F. Cesa (2001)
Pregnancy Outcome in Recurrent Spontaneous Abortion Associated with Antiphospholipid Antibodies: A Comparative Study of Intravenous Immunoglobulin Versus Prednisone Plus Low‐Dose AspirinAmerican Journal of Reproductive Immunology, 45
CE Rodrigues, JF Carvalho, Y Shoenfeld (2010)
Neurological manifestations of antiphospholipid syndromeEur J Clin Invest, 40
D. Provan, R. Stasi, A. Newland, V. Blanchette, P. Bolton-Maggs, J. Bussel, B. Chong, D. Cines, T. Gernsheimer, B. Godeau, J. Grainger, I. Greer, B. Hunt, P. Imbach, G. Lyons, R. Mcmillan, F. Rodeghiero, M. Sanz, M. Tarantino, S. Watson, Joan Young, D. Kuter (2010)
International consensus report on the investigation and management of primary immune thrombocytopenia.Blood, 115 2
C. Beyer, D. Pisetsky (2010)
The role of microparticles in the pathogenesis of rheumatic diseasesNature Reviews Rheumatology, 6
M. Tektonidou, K. Laskari, D. Panagiotakos, H. Moutsopoulos (2008)
Risk factors for thrombosis and primary thrombosis prevention in patients with systemic lupus erythematosus with or without antiphospholipid antibodies.Arthritis and rheumatism, 61 1
M. Amigo (2014)
What do we know about the cardiac valve lesion in the antiphospholipid syndrome (APS)?Lupus, 23
M. Galli, T. Barbui, R. Zwaal, P. Comfurius, E. Bevers (1993)
Antiphospholipid antibodies: involvement of protein cofactors.Haematologica, 78 1
E. Harris (1994)
Diagnosis and management of antiphospholipid syndrome.Hospital practice, 29 4
P. Meroni, A. Tincani, N. Sepp, E. Raschi, C. Testoni, E. Corsini, I. Cavazzana, S. Pellegrini, A. Salmaggi (2003)
Endothelium and the brain in CNS lupusLupus, 12
S. Jiménez, D. Tàssies, G. Espinosa, Ángeles García-Criado, Joan Plaza, J. Monteagudo, R. Cervera, J. Reverter (2007)
Double heterozygosity polymorphisms for platelet glycoproteins Ia/IIa and IIb/IIIa increases arterial thrombosis and arteriosclerosis in patients with the antiphospholipid syndrome or with systemic lupus erythematosusAnnals of the Rheumatic Diseases, 67
G. Sebastiani, G. Passiu, M. Galeazzi, F. Porzio, U. Carcassi (1991)
Prevalence and clinical associations of anticardiolipin antibodies in systemic lupus erythematosus: A prospective studyClinical Rheumatology, 10
H. Versteeg, W. Ruf (2011)
Thiol pathways in the regulation of tissue factor prothrombotic activityCurrent Opinion in Hematology, 18
J. Kaburaki, M. Kuwana, M. Yamamoto, S. Kawai, Y. Ikeda (1997)
Clinical significance of anti-annexin V antibodies in patients with systemic lupus erythematosus.American journal of hematology, 54 3
G. Espinosa, R. Cervera (2015)
Current treatment of antiphospholipid syndrome: lights and shadowsNature Reviews Rheumatology, 11
R. Asherson, S. Bucciarelli, J. Gómez-Puerta, R. Cervera (2009)
Chapter 1 History, Classification, and Subsets of the Antiphospholipid Syndrome, 10
M. Petri (2006)
Epidemiology of Antiphospholipid Syndrome
J. Pereira, Gino Alfaro, M. Goycoolea, T. Quiroga, M. Ocqueteau, L. Massardo, C. Pérez, C. Sáez, O. Panes, V. Matus, D. Mezzano (2005)
Circulating platelet-derived microparticles in systemic lupus erythematosusThrombosis and Haemostasis, 95
M. Galli, D. Luciani, G. Bertolini, T. Barbui (2003)
Lupus anticoagulants are stronger risk factors for thrombosis than anticardiolipin antibodies in the antiphospholipid syndrome: a systematic review of the literature.Blood, 101 5
M. Bertolaccini, G. Hughes, M. Khamashta (2004)
Revisiting antiphospholipid antibodies: from targeting phospholipids to phospholipid binding proteins.Clinical laboratory, 50 11-12
R. Levy, F. Santos, G. Jesús, N. Jesús (2015)
Antiphospholipid Antibodies and Antiphospholipid Syndrome during Pregnancy: Diagnostic ConceptsFrontiers in Immunology, 6
L. Opatrny, M. David, S. Kahn, I. Shrier, E. Rey (2006)
Association between antiphospholipid antibodies and recurrent fetal loss in women without autoimmune disease: a metaanalysis.The Journal of rheumatology, 33 11
M. Biggioggero, P. Meroni (2010)
The geoepidemiology of the antiphospholipid antibody syndrome.Autoimmunity reviews, 9 5
K. Habe, H. Wada, Takeshi Matsumoto, K. Ohishi, M. Ikejiri, Kimiko Matsubara, Tatsuhiko Morioka, Y. Kamimoto, T. Ikeda, N. Katayama, H. Mizutani (2016)
Presence of Antiphospholipid Antibodies as a Risk Factor for Thrombotic Events in Patients with Connective Tissue Diseases and Idiopathic Thrombocytopenic Purpura.Internal medicine, 55 6
S Sciascia, MJ Cuadrado, M Khamashta, D Roccatello (2014)
Renal involvement in antiphospholipid syndromeNat Rev Nephrol, 10
Teresa Pinto‐Almeida, M. Caetano, M. Sanches, M. Selores (2013)
Cutaneous manifestations of antiphospholipid syndrome: a review of the clinical features, diagnosis and management.Acta reumatologica portuguesa, 38 1
I. Næss, S. Christiansen, S. Cannegieter, F. Rosendaal, J. Hammerstroem (2006)
A prospective study of anticardiolipin antibodies as a risk factor for venous thrombosis in a general population (the HUNT study)Journal of Thrombosis and Haemostasis, 4
RA Asherson (1992)
The catastrophic antiphospholipid syndromeJ Rheumatol, 19
B. Alchi, M. Griffiths, D. Jayne (2010)
What nephrologists need to know about antiphospholipid syndrome.Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association, 25 10
D. Sène, J. Piette, P. Cacoub (2009)
Anticorps antiphospholipide, syndrome des anticorps antiphospholipides et infections viralesRevue de Médecine Interne, 30
N. Johnson (1958)
Multivariate AnalysisNature, 182
R. Asherson (1998)
The catastrophic antiphospholipid syndrome, 1998. A review of the clinical features, possible pathogenesis and treatmentLupus, 7
E. Gharavi, H. Chaimovich, E. Cucurull, C. Celli, H. Tang, W. Wilson, A. Gharavi (1999)
Induction of antiphospholipid antibodies by immunization with synthetic viral and bacterial peptidesLupus, 8
G. Finazzi, V. Brancaccio, M. Moia, N. Ciavarella, M. Mazzucconi, P. Schinco, M. Ruggeri, E. Pogliani, G. Gamba, E. Rossi, F. Baudo, C. Manotti, A. D’Angelo, G. Palareti, V. Stefano, M. Berrettini, T. Barbui (1996)
Natural history and risk factors for thrombosis in 360 patients with antiphospholipid antibodies: a four-year prospective study from the Italian Registry.The American journal of medicine, 100 5
G. Triolo, A. Ferrante, F. Ciccia, A. Accardo-Palumbo, A. Perino, Antonio Castelli, Antonio Giarratano, G. Licata (2003)
Randomized study of subcutaneous low molecular weight heparin plus aspirin versus intravenous immunoglobulin in the treatment of recurrent fetal loss associated with antiphospholipid antibodies.Arthritis and rheumatism, 48 3
R. Cervera (2010)
Catastrophic antiphospholipid syndrome (CAPS): update from the ‘CAPS Registry’Lupus, 19
A. Katzav, J. Chapman, Y. Shoenfeld (2003)
CNS dysfunction in the antiphospholipid syndromeLupus, 12
E. Clark, R. Silver, D. Branch (2007)
Do antiphospholipid antibodies cause preeclampsia and HELLP syndrome?Current Rheumatology Reports, 9
A. Tincani, G. Balestrieri, L. Spatola, M. Cinquini, P. Meroni, R. Roubey (1998)
Anticardiolipin and anti-beta 2glycoprotein I immunoassays in the diagnosis of antiphospholipid syndrome.Clinical and experimental rheumatology, 16 4
D. Sène, J. Piette, P. Cacoub (2008)
Antiphospholipid antibodies, antiphospholipid syndrome and infections.Autoimmunity reviews, 7 4
V. Pengo, A. Ruffatti, C. Legnani, S. Testa, T. Fierro, F. Marongiu, V. Micheli, P. Gresele, M. Tonello, A. Ghirarduzzi, E. Bison, G. Denas, A. Banzato, S. Jose, S. Iliceto (2011)
Incidence of a first thromboembolic event in asymptomatic carriers of high-risk antiphospholipid antibody profile: a multicenter prospective study.Blood, 118 17
A. Ruffatti, M. Tonello, A. Cavazzana, P. Bagatella, V. Pengo (2009)
Laboratory classification categories and pregnancy outcome in patients with primary antiphospholipid syndrome prescribed antithrombotic therapy.Thrombosis research, 123 3
R. Levy, J. Gómez-Puerta, R. Cervera (2017)
History, Classification, and Subsets of the Antiphospholipid Syndrome, 12
M. Hojnik, J. George, L. Ziporen, Y. Shoenfeld (1996)
Heart valve involvement (Libman-Sacks endocarditis) in the antiphospholipid syndrome.Circulation, 93 8
L. Andreoli, C. Chighizola, A. Banzato, G. Pons-Estel, G. Jesús, D. Erkan (2013)
Estimated Frequency of Antiphospholipid Antibodies in Patients With Pregnancy Morbidity, Stroke, Myocardial Infarction, and Deep Vein Thrombosis: A Critical Review of the LiteratureArthritis Care & Research, 65
C. Mackworth-Young, S. Loizou, M. Walport (1989)
Primary antiphospholipid syndrome: features of patients with raised anticardiolipin antibodies and no other disorder.Annals of the Rheumatic Diseases, 48
M. Galli, T. Barbui, P. Comfurius, C. Maassen, H. Hemker, R. Zwaal, E. Bevers, M. Baets, P.J.C. Breda-Vriesman (1990)
Anticardiolipin antibodies (ACA) directed not to cardiolipin but to a plasma protein cofactorThe Lancet, 335
JD Oosting, RH Derksen, IW Bobbink, T. Hackeng, BN Bouma, P. Groot (1993)
Antiphospholipid antibodies directed against a combination of phospholipids with prothrombin, protein C, or protein S: an explanation for their pathogenic mechanism?Blood, 81 10
S. Gysler, M. Mulla, Marta Guerra, J. Brosens, J. Salmon, L. Chamley, V. Abrahams (2016)
Antiphospholipid antibody-induced miR-146a-3p drives trophoblast interleukin-8 secretion through activation of Toll-like receptor 8.Molecular human reproduction, 22 7
F. Tubach, G. Hayem, J. Marchand, M. Weber, E. Palazzo, M. Bandt, S. Roux, M. Kahn, O. Meyer (2000)
IgG anti-beta2-glycoprotein I antibodies in adult patients with systemic lupus erythematosus: prevalence and diagnostic value for the antiphospholipid syndrome.The Journal of rheumatology, 27 6
A. Martínez-Berriotxoa, G. Ruiz‐Irastorza, M. Egurbide, M. Garmendia, Jose Erdozain, I. Villar, C. Aguirre (2007)
Transiently positive anticardiolipin antibodies and risk of thrombosis in patients with systemic lupus erythematosusLupus, 16
L. Durcan, M. Petri (2017)
Epidemiology of the Antiphospholipid Syndrome, 12
A. Vikerfors, F. Mobarrez, K. Bremme, M. Holmström, A. Ågren, A. Eelde, M. Bruzelius, A. Antovic, H. Wallén, E. Svenungsson (2012)
Studies of microparticles in patients with the antiphospholipid syndrome (APS)Lupus, 21
D. Wallace, M. Linker‐Israeli, A. Metzger, V. Stecher (1993)
The Relevance of Antimalarial Therapy with Regard to Thrombosis, Hypercholesterolemia and Cytokines in SLELupus, 2
Jallow Tracy, D’Cruz David, L. Heidi, 朱剑, 王一雯, 黄烽 (2017)
Antiphospholipid syndromeBMJ, 20
Roderick Fields, H. Toubbeh, Searles Rp, A. Bankhurst (1989)
The prevalence of anticardiolipin antibodies in a healthy elderly population and its association with antinuclear antibodies.The Journal of rheumatology, 16 5
D. Erkan, Cassyanne Aguiar, D. Andrade, H. Cohen, M. Cuadrado, Adriana Danowski, R. Levy, T. Ortel, Anisur Rahman, J. Salmon, M. Tektonidou, R. Willis, M. Lockshin (2014)
14th International Congress on Antiphospholipid Antibodies: task force report on antiphospholipid syndrome treatment trends.Autoimmunity reviews, 13 6
L. Horstman, W. Jy, A. Minagar, Carlos Bidot, J. Jimenez, J. Alexander, Y. Ahn (2007)
Cell-derived microparticles and exosomes in neuroinflammatory disorders.International review of neurobiology, 79
I. Rodríguez-Pintó, G. Espinosa, R. Cervera (2014)
The Catastrophic Antiphospholipid SyndromeAntiphospholipid Antibody Syndrome
D. Sène, J. Piette, P. Cacoub (2009)
[Antiphospholipid antibodies, antiphospholipid syndrome and viral infections].La Revue de medecine interne, 30 2
Z. Sthoeger, D. Sthoeger, L. Green, D. Geltner (1993)
The role of anticardiolipin autoantibodies in the pathogenesis of autoimmune hemolytic anemia in systemic lupus erythematosus.The Journal of rheumatology, 20 12
V. Pengo, A. Tripodi, G. Reber, J. Rand, T. Ortel, M. Galli, D. Groot (2009)
Update of the guidelines for lupus anticoagulant detectionJournal of Thrombosis and Haemostasis, 7
F. Azevedo, Diego Maia, J. Carvalho, C. Rodrigues (2018)
Renal involvement in antiphospholipid syndromeRheumatology International, 38
Shannon Bates, I Greer, Saskia Middeldorp, David Veenstra, A. Prabulos, P. Vandvik (2012)
VTE, thrombophilia, antithrombotic therapy, and pregnancy: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines.Chest, 141 2 Suppl
T. Barnini, E. Silvestri, G. Emmi, M. D’Elios, E. Beccastrini, D. Squatrito, L. Emmi, D. Prisco (2012)
Pulmonary fibrosis and lymphocytic alveolitis associated with triple antiphospholipid antibody positivity: a diagnostic puzzle.Clinical and experimental rheumatology, 30 5
P. Meroni, C. Chighizola, F. Rovelli, M. Gerosa (2014)
Antiphospholipid syndrome in 2014: more clinical manifestations, novel pathogenic players and emerging biomarkersArthritis Research & Therapy, 16
M. Wislowska (2015)
[Catastrophic antiphospholipid syndrome].Wiadomosci lekarskie, 68 3
R. Urbanus, B. Siegerink, M. Roest, F. Rosendaal, P. Groot, A. Algra (2009)
Antiphospholipid antibodies and risk of myocardial infarction and ischaemic stroke in young women in the RATIO study: a case-control studyThe Lancet Neurology, 8
E. Pol, A. Böing, P. Harrison, A. Sturk, R. Nieuwland (2012)
Classification, Functions, and Clinical Relevance of Extracellular VesiclesPharmacological Reviews, 64
C. Kearon, E. Akl, A. Comerota, P. Prandoni, H. Bounameaux, S. Goldhaber, M. Nelson, P. Wells, M. Gould, F. Dentali, M. Crowther, S. Kahn (2012)
Antithrombotic therapy for VTE disease: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines.Chest, 141 2 Suppl
Taraneh Mehrani, M. Petri (2009)
Chapter 2 Epidemiology of the Antiphospholipid Syndrome, 10
C. Mok, Sandy Tang, C. To, M. Petri (2005)
Incidence and risk factors of thromboembolism in systemic lupus erythematosus: a comparison of three ethnic groups.Arthritis and rheumatism, 52 9
D Sene, JC Piette, P Cacoub (2009)
Antiphospholipid antibodies, antiphospholipid syndrome and viral infectionsRev Med Intern, 30
E. Niccolai, G. Emmi, D. Squatrito, E. Silvestri, L. Emmi, A. Amedei, D. Prisco (2015)
Microparticles: Bridging the Gap between Autoimmunity and ThrombosisSeminars in Thrombosis & Hemostasis, 41
G. Ruiz‐Irastorza, B. Hunt, M. Khamashta (2007)
A systematic review of secondary thromboprophylaxis in patients with antiphospholipid antibodies.Arthritis and rheumatism, 57 8
S. Levine, L. Salowich-Palm, K. Sawaya, M. Perry, H. Spencer, H. Winkler, Zarina Alam, J. Carey (1997)
IgG anticardiolipin antibody titer > 40 GPL and the risk of subsequent thrombo-occlusive events and death. A prospective cohort study.Stroke, 28 9
R. Rai, T. Swetha (2015)
Association of anti-phospholipid antibodies with connective tissue diseasesIndian Dermatology Online Journal, 6
C. Francès, S. Niang, E. Laffitte, F. Pelletier, N. Costedoat, J. Piette (2005)
Dermatologic manifestations of the antiphospholipid syndrome: two hundred consecutive cases.Arthritis and rheumatism, 52 6
D. Erkan, J. Merrill, Y. Yazici, L. Sammaritano, J. Buyon, M. Lockshin (2001)
High thrombosis rate after fetal loss in antiphospholipid syndrome: effective prophylaxis with aspirin.Arthritis and rheumatism, 44 6
M. Kanakis, V. Kapsimali, A. Vaiopoulos, G. Vaiopoulos, M. Samarkos (2013)
The lung in the spectrum of antiphospholipid syndrome.Clinical and experimental rheumatology, 31 3
G. Šukara, M. Barešić, M. Sentíc, L. Brčić, B. Anić (2015)
Catastrophic antiphospholipid syndrome associated with systemic lupus erythematosus treated with rituximab: case report and a review of the literature.Acta reumatologica portuguesa, 40 2
Maurizio Sorice, P. Arcieri, T. Griggi, A. Circella, R. Misasi, L. Lenti, G. Nucci, Guglielmo Mariani (1996)
Inhibition of Protein S by Autoantibodies in Patients with Acquired Protein S DeficiencyThrombosis and Haemostasis, 75
R. Cervera, R. Asherson, M. Acevedo, J. Gómez-Puerta, G. Espinosa, G. Red, V. Gil, M. Ramos-Casals, M. García-Carrasco, M. Ingelmo, J. Font (2004)
Antiphospholipid syndrome associated with infections: clinical and microbiological characteristics of 100 patientsAnnals of the Rheumatic Diseases, 63
O. Amengual, T. Atsumi, M. Khamashta, G. Hughes (1998)
The Role of the Tissue Factor Pathway in the Hypercoagulable State in Patients with the Antiphospholipid SyndromeThrombosis and Haemostasis, 79
A. Popa, L. Voinea, M. Pop, D. Stana, A. Dascalu, C. Alexandrescu, R. Ciuluvică (2008)
[Primary antiphospholipid syndrome].Oftalmologia, 52 1
R. Brey (2004)
New treatment option for the antiphospholipid antibody syndrome? More pleiotropic effects of the statin drugsJournal of Thrombosis and Haemostasis, 2
Silvia Pierangeli1, Pojen Chen2, Elena Raschi3, Silvia Scurati3, Claudia Grossi3, Maria Borghi3, Ivan Palomo4, E. Harris5, Pier Meroni3 (2008)
Antiphospholipid Antibodies and the Antiphospholipid Syndrome: Pathogenic MechanismsSemin Thromb Hemost, 34
G. Girardi, Jessica Berman, P. Redecha, Lynn Spruce, J. Thurman, Damian Kraus, Travis Hollmann, Paolo Casali, M. Caroll, Rick Wetsel, John Lambris, V. Holers, Jane Salmon (2003)
Complement C5a receptors and neutrophils mediate fetal injury in the antiphospholipid syndrome.The Journal of clinical investigation, 112 11
M. Bertolaccini, S. Gómez, J. Pareja, A. Theodoridou, G. Sanna, G. Hughes, M. Khamashta (2005)
Antiphospholipid antibody tests: spreading the netAnnals of the Rheumatic Diseases, 64
Di Nicoletta, Raschi Elena, Testoni Cinzia, Castellani Roberto, D. Marco, Shi Tao, Krilis Steven, Caruso Alessandro, P. Meroni (2004)
Pathogenic role of anti-β2-glycoprotein I antibodies in antiphospholipid associated fetal loss: characterisation of β2-glycoprotein I binding to trophoblast cells and functional effects of anti-β2-glycoprotein I antibodies in vitroAnnals of the Rheumatic Diseases, 64
Jennifer Lee, S. Naguwa, G. Cheema, M. Gershwin (2009)
Revisiting Libman–Sacks Endocarditis: A Historical Review and UpdateClinical Reviews in Allergy & Immunology, 36
J. Rand, Xiao-Xuan Wu, H. Andree, Charles Lockwood, S. Guller, J. Scher, P. Harpel (1997)
Pregnancy loss in the antiphospholipid-antibody syndrome--a possible thrombogenic mechanism.The New England journal of medicine, 337 3
J. Hunt, S. Krilis (1994)
The fifth domain of beta 2-glycoprotein I contains a phospholipid binding site (Cys281-Cys288) and a region recognized by anticardiolipin antibodies.Journal of immunology, 152 2
Antiphospholipid antibody syndrome (APS) is an autoimmune acquired thrombophilia characterized by recurrent thrombosis and pregnancy morbidity in the presence of antiphospholipid antibodies (aPL). APS can be primary, if it occurs in the absence of any underlying disease, or secondary, if it is associated with another autoimmune disorder, most commonly systemic lupus erythematosus. The exact pathogenetic mechanism of APS is unknown, but different, not mutually exclusive, models have been proposed to explain how anti-PL autoantibodies might lead to thrombosis and pregnancy morbidity. Diagnosis of APS requires that a patient has both a clinical manifestation (arterial or venous thrombosis and/or pregnancy morbidity) and persistently positive aPL, but the clinical spectrum of the disease encompasses additional manifestations which may affect every organ and cannot be explained exclusively by a prothrombotic state. Treatment for aPL-positive patients is based on the patient’s clinical status, presence of an underlying autoimmune disease, and history of thrombotic events. In case of aPL positivity without previous thrombotic events, the treatment is mainly focused on reduction of additional vascular risk factors, while treatment of patients with definite APS is based on long-term anticoagulation. Pregnancy complications are usually managed with low-dose aspirin in association with low molecular weight heparin. Refractory forms of APS could benefit from adding hydroxychloroquine and/or intravenous immunoglobulin to anticoagulation therapy. Promising novel treatments include anti-B cell monoclonal antibodies, new-generation anticoagulants, and complement cascade inhibitors. The objective of this review paper is to summarize the recent literature on APS from pathogenesis to current therapeutic options.
Clinical and Experimental Medicine – Springer Journals
Published: Jun 22, 2016
Read and print from thousands of top scholarly journals.
Already have an account? Log in
Bookmark this article. You can see your Bookmarks on your DeepDyve Library.
To save an article, log in first, or sign up for a DeepDyve account if you don’t already have one.
Copy and paste the desired citation format or use the link below to download a file formatted for EndNote
Access the full text.
Sign up today, get DeepDyve free for 14 days.
All DeepDyve websites use cookies to improve your online experience. They were placed on your computer when you launched this website. You can change your cookie settings through your browser.